Adult T-cell Lymphoma

Adult T-cell Lymphoma is a rare type of cancer that affects the body's immune system, specifically the T-cells, which help fight infections. This disease mainly impacts the lymphatic system, a network of tissues and organs that help protect the body from illness. People with this condition may develop swollen lymph nodes, skin lesions, and symptoms like fatigue or weight loss. The cancerous T-cells grow uncontrollably and can spread to other parts of the body, causing serious health problems. It is caused by infection with a virus called human T-cell lymphotropic virus type 1 (HTLV-1), which changes the normal function of T-cells. Early detection is important because the disease can progress quickly and affect overall health.

Adult T-cell Lymphoma (ATL) is a malignancy of mature CD4+ T-lymphocytes caused by chronic infection with human T-cell lymphotropic virus type 1 (HTLV-1). The virus integrates into host DNA, leading to oncogenic transformation through viral proteins such as Tax and HBZ, which promote uncontrolled T-cell proliferation and inhibit apoptosis. ATL is characterized by aggressive clinical behavior with manifestations including generalized lymphadenopathy, hepatosplenomegaly, skin lesions, hypercalcemia, and immunosuppression. It is classified into several clinical subtypes: acute, lymphoma, chronic, and smoldering, each with distinct prognosis and treatment responses. The disease is endemic in certain regions such as southwestern Japan, the Caribbean, and parts of Africa. Diagnosis and management require recognition of the viral etiology and the aggressive nature of the lymphoma.